Allos (ALTH) Drops 16%+ as $2.20/Share Offer Withdrawn
Tweet
Share
E-mailGet Alerts ALTH Hot Sheet
Join SI Premium – FREE
Allos Therapeutics (Nasdaq: ALTH) is dipping today, following a broken buyout offer of $2.20 from an undisclosed publicly-traded pharmaceutical company.
Shares are down 16 percent on the session.
Click here for more from that report.
Shares are down 16 percent on the session.
Click here for more from that report.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Conmed weighing sale after takeover interest - Bloomberg
- Qiagen Is Said To Draw Takeover Interest From Eqt, Advent - Bloomberg
- Carlyle to sell Copia Power to EQT - FT
Create E-mail Alert Related Categories
Insiders' Blog, Mergers and Acquisitions, Momentum MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
